Eclipse
- Risk class
- Class IIa
- CND nomenclatures code
- Z12159004
- Trade name
- ECLIPSE
- Implantable
- No
- Reusable
- No
- Measuring function
- No
- Primary DI
- M766690008SEQ0
- Basic UDI
- B-M766690008SEQ0
- Version date
- February 04, 2025
- Manufacturer last update
- September 24, 2024
- Active status
- Yes
- Manufacturer name
- CAIRE Inc.
- Country
- United States
- Country type
- NON_EU
- Address
- 2200 Airport Industrial drive Ball Ground
- pamela.netzel@caireinc.com
- SRN
- DE-AR-000005009
- Country
- Germany
- Address
- 20 Borngasse Braunfels
- g.froemel@mps-gmbh.eu
- Telephone
- +49 6442962073
- Competent authority
- DE/CA36 - Regierungspräsidium Gießen Abteilung II_Dezernat 25.1 - Arbeitsschutz Gießen I
- Applicable legislation
- MDD (Directive 93/42/EEC on Medical Devices)
- Placed on the market
- Germany
- Market available
- Germany:2016-06-22~2028-12-31, Ireland:2016-06-22~2028-12-31
- Human tissues
- No
- Animal tissues
- No
OXYGEN CONCENTRATORS
Access comprehensive regulatory information for Eclipse in the European Union medical device market through Pure Global AI's free database. This Class IIa device is registered with EU EUDAMED under Primary DI M766690008SEQ0 and manufactured by CAIRE Inc. in United States.
This page provides complete registration details including trade name (ECLIPSE), manufacturer information, authorized representative details, competent authority (DE/CA36 - Regierungspräsidium Gießen Abteilung II_Dezernat 25.1 - Arbeitsschutz Gießen I), and regulatory compliance data from the official EU EUDAMED medical device database. Pure Global AI offers free access to the European Union's complete medical device registry, helping global MedTech companies navigate EU MDR regulations efficiently.